Patent · US Active

Compositions for treating joints comprising bone morphogenetic protein and hyaluronic acid

US9561260B2 · kind B2 · utility

0Cited by
81References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 3, 2014
Grant dateFeb 7, 2017
Priority date
Expiry dateDec 3, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M39/223
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions are disclosed for an intra-articular injection for the treatment of osteoarthritis. The methods and compositions comprising combinations of hyaluronic acid and a bone morphogenetic protein, like rhGDF-5, can be useful for any synovial joint, including the knee, shoulder, hip, ankle, hands, spinal facet, or temporomandibular joint, both for the relief of pain and for slowing disease progression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.